# clm_63C6CFD02CA4

subject: Vertex Pharmaceuticals (/record/vertex-pharmaceuticals.md)  
predicate: quarterly_operating_income  
value: 99,333,000 United States dollar  
valid_from: 2019-09-30  
valid_to: 2020-03-31  
published: 2019-10-31  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_EB1B0B642262  
last_updated: 2026-11-08  
cite: AsOf. "Vertex Pharmaceuticals quarterly operating income: 99,333,000 United States dollar", as of 2019-09-30 (until 2020-03-31). Claim clm_63C6CFD02CA4, https://asof.is/claim/clm_63C6CFD02CA4, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/875320/000087532019000057/0000875320-19-000057-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2019, filed 2019-10-31  

## Sources

- https://www.sec.gov/Archives/edgar/data/875320/000087532019000057/0000875320-19-000057-index.htm (primary, SEC EDGAR 10-Q Q3 FY2019, published 2019-10-31)

## Supersedes

- [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | quarterly_operating_income | 269,960,000 United States dollar | valid 2019-06-30 to 2019-09-30 | conf 0.95 | superseded | superseded_by [clm_63C6CFD02CA4](/claim/clm_63C6CFD02CA4.md) | [clm_3837B5FA4621](/claim/clm_3837B5FA4621.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.